Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA212038-002

ADHANSIA XR(METHYLPHENIDATE HYDROCHLORIDE)

Centrally acting sympathomimetics

Manufacturer: KNOA PHARMA

FDA Approval: 27/02/2019

Route: ORAL · CAPSULE, EXTENDED RELEASE

Active Ingredients

METHYLPHENIDATE HYDROCHLORIDE 35MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ADHANSIA XR — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.